日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2017/02/15 | 5,600 | 5,600 | 5,570 | 5,570 | ±0 | ±0% | 1,200 |
| 2017/02/14 | 5,600 | 5,600 | 5,530 | 5,570 | ±0 | ±0% | 2,200 |
| 2017/02/13 | 5,550 | 5,570 | 5,550 | 5,570 | +20 | +0.4% | 1,300 |
| 2017/02/10 | 5,570 | 5,570 | 5,530 | 5,550 | +10 | +0.2% | 1,100 |
| 2017/02/09 | 5,520 | 5,560 | 5,520 | 5,540 | +10 | +0.2% | 1,300 |
| 2017/02/08 | 5,530 | 5,550 | 5,520 | 5,530 | ±0 | ±0% | 1,100 |
| 2017/02/07 | 5,570 | 5,570 | 5,530 | 5,530 | -20 | -0.4% | 900 |
| 2017/02/06 | 5,540 | 5,580 | 5,540 | 5,550 | +20 | +0.4% | 2,200 |
| 2017/02/03 | 5,530 | 5,550 | 5,530 | 5,530 | ±0 | ±0% | 2,500 |
| 2017/02/02 | 5,540 | 5,540 | 5,520 | 5,530 | ±0 | ±0% | 2,500 |
| 2017/02/01 | 5,540 | 5,590 | 5,520 | 5,530 | -80 | -1.4% | 2,500 |
| 2017/01/31 | 5,610 | 5,610 | 5,600 | 5,610 | -30 | -0.5% | 1,200 |
| 2017/01/30 | 5,650 | 5,680 | 5,640 | 5,640 | +10 | +0.2% | 4,000 |
| 2017/01/27 | 5,640 | 5,640 | 5,610 | 5,630 | +30 | +0.5% | 2,900 |
| 2017/01/26 | 5,640 | 5,640 | 5,570 | 5,600 | +50 | +0.9% | 2,600 |
| 2017/01/25 | 5,620 | 5,640 | 5,540 | 5,550 | +30 | +0.5% | 3,300 |
| 2017/01/24 | 5,520 | 5,560 | 5,490 | 5,520 | ±0 | ±0% | 6,700 |
| 2017/01/23 | 5,520 | 5,530 | 5,520 | 5,520 | -60 | -1.1% | 900 |
| 2017/01/20 | 5,530 | 5,650 | 5,530 | 5,580 | +20 | +0.4% | 1,500 |
| 2017/01/19 | 5,570 | 5,660 | 5,560 | 5,560 | -40 | -0.7% | 3,800 |
| 2017/01/18 | 5,540 | 5,620 | 5,540 | 5,600 | +10 | +0.2% | 3,500 |
| 2017/01/17 | 5,570 | 5,610 | 5,550 | 5,590 | ±0 | ±0% | 4,200 |
| 2017/01/16 | 5,510 | 5,600 | 5,510 | 5,590 | +50 | +0.9% | 2,600 |
| 2017/01/13 | 5,500 | 5,540 | 5,500 | 5,540 | +10 | +0.2% | 3,100 |
| 2017/01/12 | 5,620 | 5,620 | 5,510 | 5,530 | -10 | -0.2% | 3,600 |
| 2017/01/11 | 5,630 | 5,630 | 5,520 | 5,540 | -100 | -1.8% | 3,100 |
| 2017/01/10 | 5,700 | 5,700 | 5,540 | 5,640 | ±0 | ±0% | 3,500 |
| 2017/01/06 | 5,780 | 5,790 | 5,620 | 5,640 | -130 | -2.3% | 4,300 |
| 2017/01/05 | 5,550 | 5,770 | 5,540 | 5,770 | +220 | +4% | 6,900 |
| 2017/01/04 | 5,460 | 5,550 | 5,460 | 5,550 | +100 | +1.8% | 4,000 |
| 2016/12/30 | 5,550 | 5,550 | 5,440 | 5,450 | -20 | -0.4% | 2,200 |
| 2016/12/29 | 5,450 | 5,500 | 5,410 | 5,470 | +20 | +0.4% | 4,400 |
| 2016/12/28 | 5,450 | 5,470 | 5,420 | 5,450 | -40 | -0.7% | 1,800 |
| 2016/12/27 | 5,460 | 5,510 | 5,460 | 5,490 | ±0 | ±0% | 1,600 |
| 2016/12/26 | 5,470 | 5,510 | 5,460 | 5,490 | -50 | -0.9% | 3,400 |
| 2016/12/22 | 5,510 | 5,540 | 5,480 | 5,540 | +30 | +0.5% | 5,100 |
| 2016/12/21 | 5,480 | 5,510 | 5,460 | 5,510 | +30 | +0.5% | 4,700 |
| 2016/12/20 | 5,440 | 5,500 | 5,430 | 5,480 | +40 | +0.7% | 8,700 |
| 2016/12/19 | 5,500 | 5,500 | 5,420 | 5,440 | -60 | -1.1% | 6,300 |
| 2016/12/16 | 5,500 | 5,520 | 5,480 | 5,500 | ±0 | ±0% | 7,600 |
| 2016/12/15 | 5,550 | 5,550 | 5,490 | 5,500 | -20 | -0.4% | 6,200 |
| 2016/12/14 | 5,550 | 5,550 | 5,500 | 5,520 | -10 | -0.2% | 2,700 |
| 2016/12/13 | 5,500 | 5,530 | 5,490 | 5,530 | -10 | -0.2% | 2,800 |
| 2016/12/12 | 5,520 | 5,540 | 5,500 | 5,540 | +30 | +0.5% | 3,600 |
| 2016/12/09 | 5,400 | 5,510 | 5,390 | 5,510 | +10 | +0.2% | 10,600 |
| 2016/12/08 | 5,500 | 5,540 | 5,480 | 5,500 | +30 | +0.5% | 9,700 |
| 2016/12/07 | 5,670 | 5,670 | 5,460 | 5,470 | -100 | -1.8% | 8,900 |
| 2016/12/06 | 5,480 | 5,580 | 5,480 | 5,570 | +90 | +1.6% | 6,600 |
| 2016/12/05 | 5,450 | 5,480 | 5,400 | 5,480 | +30 | +0.6% | 5,500 |
| 2016/12/02 | 5,370 | 5,460 | 5,370 | 5,450 | +80 | +1.5% | 4,500 |
1901～
1950
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,100円 | +2.5% | - | 3.31% | 90.86倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ティムス | 20,500円 | - | - | 0.00% | - | 2.78倍 |
|
東京農工大発創薬ベンチャー。黒カビ由来の急性期脳梗塞薬候補品を香港拠点ジーシンに導出 |
| ノイルイミューン | 17,300円 | -97.8% | - | 0.00% | - | 1.50倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,000円 | -43.1% | - | 0.00% | - | 1.84倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
